Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-2-8
pubmed:abstractText
The requirement for the maintenance of telomeres by telomerase by most cancer cells for continued proliferation is a target in anticancer strategies. Tankyrases are poly(ADP-ribose) polymerases that enhance telomerase access to telomeres. Tankyrase 1 modulates telomerase inhibition in human cancer cells and is reviewed in this report as a potential telomere-directed anticancer target.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-10500096, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-10502820, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-10523501, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-10988299, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-11069113, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-11278563, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-11454873, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-11739745, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-11854288, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-12080061, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-12475993, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-12479362, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-12589701, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-12782650, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-14608368, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-14966275, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15064417, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15133513, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15189140, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15256453, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15500951, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15509784, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15577915, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15652747, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15795250, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15829966, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-15829967, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-16076287, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-16244666, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-7605428, http://linkedlifedata.com/resource/pubmed/commentcorrection/16421589-9822378
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
341-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
The telomeric PARP, tankyrases, as targets for cancer therapy.
pubmed:affiliation
Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan. hseimiya@jfcr.or.jp
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't